Histological grading and MIB-1 labeling index of soft-tissue sarcomas

Pathology International

Volumn 57, Issue 3, 2007, Pages 121-125

  Hasegawa, Tadashi ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

FNCLCC system; Histological grading; Management; MIB 1 labeling index; Prognostic factor; Soft tissue sarcomas

Indexed keywords

KI 67 ANTIGEN; TUMOR MARKER;

ANTIBODY LABELING; CANCER CLASSIFICATION; CANCER GRADING; CELL PROLIFERATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SOFT TISSUE SARCOMA;

CELL COUNT; CELL PROLIFERATION; HUMANS; KI-67 ANTIGEN; PROGNOSIS; SARCOMA; SOFT TISSUE NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 33846895392     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2006.02068.x     Document Type: Review

References (15)

1. Fletcher CDM, Rydholm A, Singer S, Sundaram M, Coindre JM. Soft tissue tumours: Epidemiology, clinical features, histopathological typing and grading. In: Fletcher CDM, Unni KK, Mertens F, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon: IARC Press, 2002; 12-18.
2. Guillou L, Coindre JM, Bonichon F et al. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol 1997; 15: 350-62.
3. Coindre JM, Terrier P, Bui NB et al. Prognostic factors in adult patients with locally controlled soft tissue sarcoma: A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J Clin Oncol 1996; 14: 869-77.
4. Hasegawa T, Yamamoto S, Matsuno Y. Quantitative immunohistochemical evaluation of MIB-1 labeling index in adult soft-tissue sarcomas by computer-assisted image analysis. Pathol Int 2002; 52: 433-7.
5. Hasegawa T, Yokoyama R, Lee YH, Shimoda T, Beppu Y, Hirohashi S. Prognostic relevance of a histological grading system using MIB-1 for adult soft-tissue sarcoma. Oncology 2000; 58: 66-74.
6. Hasegawa T, Yamamoto S, Yokoyama R, Umeda T, Matsuno Y, Hirohashi S. Prognostic significance of grading and staging systems using MIB-1 score in adult patients with soft tissue sarcoma of the extremities and trunk. Cancer 2002; 95: 843-51.
7. Hasegawa T, Seki K, Hasegawa F et al. Dedifferentiated liposarcoma of retroperitoneum and mesentery: Varied growth patterns and histologic grades - a clinicopathologic study of 32 cases. Hum Pathol 2000; 31: 717-27.
8. Tateishi U, Hasegawa T, Beppu Y, Kawai A, Moriyama N. Prognostic significance of grading (MIB-1 system) in patients with myxoid liposarcoma. J Clin Pathol 2003; 56: 579-82.
9. Hasegawa T, Yokoyama R, Matsuno Y, Shimoda T, Hirohashi S. Prognostic significance of histologic grade and nuclear expression of β-catenin in synovial sarcoma. Hum Pathol 2001; 32: 257-63.
10. Hasegawa T, Matsuno Y, Shimoda T, Hirohashi S. Gastrointestinal stromal tumor: Consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade. Hum Pathol 2002; 33: 669-76.
11. Hasegawa T, Yamamoto S, Nojima T et al. Validity and reproducibility of histologic diagnosis and grading for adult soft-tissue sarcomas. Hum Pathol 2002; 33: 111-15.
12. Yamaguchi U, Hasegawa T, Sakurai S et al. Interobserver variability in histologic recognition, interpretation of KIT immunostaining and determining MIB-1 labeling indices in gastrointestinal stromal tumors and other spindle cell tumors of the gastrointestinal tract. Appl Immunohistochem Mol Morphol 2006; 14: 46-51.
13. Coindre JM, Terrier P, Guillou L et al. Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas. A study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer 2001; 91: 1914-26.
14. Tateishi U, Yamaguchi U, Seki K, Terauchi T, Arai Y, Hasegawa T. Glut-1 expression and enhanced glucose metabolism are associated with tumor grade in bone and soft tissue sarcomas: A prospective evaluation by [F-18]- fluorodeoxyglucose positron emission tomography. Eur J Nucl Med Mol Imaging 2006; 33: 683-91.
15. Sato O, Wada T, Kawai A et al. Expression of epidermal growth factor receptor, HER2/neu, and CD117/c-kit in adult soft tissue sarcomas: A clinicopathological study of 281 cases. Cancer 2005; 103: 1881-90.